nivolumab,relatlimab
bms
['relativity-047', 'melanoma']
outstanding #asco2022 update by of os &amp; orr by key subgroups from relativity-047 in pts with untreated metastatic or unresectable #melanoma 
MD, #melanoma surgical oncologist-investigator at The University of Texas MD Anderson Cancer Center @MDAndersonNews ~ views are my own #endcancer